Related Experiment Videos
[Silent myocardial ischemia in patients with essential hypertension]
Insights
Silent ST segment depression in essential hypertension patients indicates myocardial ischemia. Elevated norepinephrine levels were observed during silent ischemia, correlating with perfusion defects and cardiac changes.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Essential hypertension is a common cardiovascular risk factor.
- Silent myocardial ischemia can occur in hypertensive patients.
- Holter monitoring and myocardial scintigraphy are diagnostic tools.
Purpose of the Study:
- To investigate the characteristics of silent myocardial ischemia in essential hypertension.
- To correlate Holter findings with exercise myocardial scintigraphy results.
- To explore the role of norepinephrine in silent ischemia.
Main Methods:
- Holter monitoring in 61 essential hypertension patients.
- Exercise myocardial scintigraphy to assess perfusion defects.
- Analysis of myocardial hypertrophy, platelet aggregation, and coronary atherosclerosis.
Main Results:
- 34 patients had painless, silent ST segment depression.
- Group 1 (no abnormal clearance) showed more hypertrophy and platelet aggregation.
- Group 2 (abnormal clearance) had less hypertrophy and platelet aggregation, with more coronary atherosclerosis.
- Both groups exhibited elevated plasma norepinephrine during silent ischemia.
Conclusions:
- Silent ST depression in hypertension is linked to transient myocardial perfusion defects.
- Norepinephrine levels rise during silent myocardial ischemia.
- Hypertensive patients with silent ischemia may have varying degrees of cardiac changes.
Abstract:
Holter monitoring was performed in 61 patients with essential hypertension. Painless, silent ST segment depression was found in 34 patients. Exercise myocardial scintigraphy indicated the occurrence of transient perfusion defects without abnormal clearance (Group 1) and those with abnormal clearance (Group 2). The patients from Group 1 showed more severe myocardial hypertrophy, higher platelet aggregation, coronary atherosclerosis was detected in 1 case. The patients from Group 2 exhibited less myocardial hypertrophy, lower platelet aggregation. Coronary atherosclerosis was revealed in 4 cases. The patients from the two groups had elevated plasma norepinephrine levels at the onset of silent myocardial ischemia.